Aebi-PoppK, DuppenthalerA, RauchA, et al.Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland. J Virus Erad, 2016; 2:52–54.
2.
AfzalMS, AnjumS, and ZaidiNU. Effect of functional interleukin-10 polymorphism on pegylated interferon-α plus ribavirin therapy response in chronic hepatitis C virus patients infected with 3a genotype in pakistani population. Hepat Mon, 2013; 13:e10274.
3.
AfzalMS, KhanMY, AmmarM, et al.Diagnostically untypable hepatitis C virus variants: it is time to resolve the problem. World J Gastroenterol, 2014; 20:17690–17692.
4.
AfzalMS, ShahZH, and AhmedH. Recent HCV genotype changing pattern in the Khyber Pakhtunkhwa province of Pakistan; is it pointing out a forthcoming problem?. Braz J Infect Dis, 2016; 20:312–313.
5.
AfzalMS. Are efforts up to the mark? A cirrhotic state and knowledge about HCV prevalence in general population of Pakistan. Asian Pac J Trop Med, 2016; 9:616–618.
6.
AfzalMS. Hepatitis C virus and interferon-free antiviral therapeutics revolution: implications for Pakistan. Viral Immunol, 2017; 30:252–257.
7.
AlaeiK, SarwarM, JuanSC, et al.Healthcare and the preventable silent killer: the growing epidemic of hepatitis C in Pakistan. Hepat Mon, 2016; 16:e41262.
8.
AliI, SiddiqueL, RehmanLU, et al.Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa. Virol J, 2011; 8:296.
9.
AliSA, DonahueRM, QureshiH, et al.Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis, 2009; 13:9–19.
10.
ArshadA, and AshfaqUA. Epidemiology of hepatitis C infection in Pakistan: current estimate and major risk factors. Crit Rev Eukaryot Gene Expr, 2017; 27:63–77.
11.
AslamMN, NadeemM, and QureshiUF. Hepatitis B And C. Prevalence in south Punjab population. Professional Med J, 2016; 23:025–028.
12.
AzizS, MuzaffarR, HafizS, et al.Helicobacter pylori, hepatitis viruses a, c, e, antibodies and hbsag—prevalence and associated risk factors in pediatric communities of karachi. J Coll Physicians Surg Pak, 2007; 17:195–198.
13.
CapilenoYA, Van den BerghR, DonchunkD, et al.Management of chronic hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan. PLoS One, 2017; 12:e0175562.
14.
FayyazM, GhousSM, UllahF, et al.Frequency of hepatitis B and C in patients seeking treatment at the dental section of a tertiary care hospital. J Ayub Med Coll Abbottabad, 2015; 27:395–397.
15.
FDI (International Dental Federation) Basic Fact Sheet, 2003. Available at https://www.omd.pt/noticias/2014/03/fdioralhealthworldwide.pdf (Accessed May1, 2017).
16.
GemelasJ, LockerR, RuddS, et al.Impact of screening implementing HCV screening of Persons Born 1945–1965: a primary care case study. J Prim Care Community Health, 2016; 7:30–32.
17.
IdreesM, LalA, NaseemM, et al.High prevalence of hepatitis C virus infection in the largest province of Pakistan. J Dig Dis, 2008; 9:95–103.
18.
IslamN, KrajdenM, ShovellerJ, et al.British Columbia Hepatitis Testers Cohort (BC-HTC) team. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study. Lancet Gastroenterol Hepatol, 2017; 2:200–210.
19.
JafriW, JafriN, YakoobJ, et al.Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006, 23; 6:101.
20.
JanjuaNZ, and NizamyMA. Knowledge and practices of barbers about hepatitis B and C transmission in Rawalpindi and Islamabad. J Pak Med Assoc, 2004; 54:116–119.
21.
JokhioAH, BhattiTA, and MemonS. Knowledge, attitudes and practices of barbers about hepatitis B and C transmission in Hyderabad, Pakistan. East Mediterr Health J, 2010; 16:1079–1084.
22.
KasraianL, NegarestaniN, KarimiMH, et al.A Survey on the prevalence of depression in blood donors with hepatitis C in Shiraz. Hepat Mon, 2016; 16:e31080.
23.
KhanAA, SaleemM, QureshiH, et al.Comparison of need and supply of syringes for therapeutic injections in Pakistan. J Pak Med Assoc, 2012; 62:1149–1153.
24.
KhanS, AttaullahS, AliI, et al.Rising burden of hepatitis C Virus in hemodialysis patients. Virol J, 2011; 8:438.
25.
KhokharN, AlamAY, NazF, et al.Risk factors for hepatitis C virus infection in patients on long-term hemodialysis. J Coll Physicians Surg Pak, 2005; 15:326–328.
26.
LebovicsE, and CzoborK. Screening, diagnosis, treatment, and management of hepatitis C: a novel, comprehensive, online resource center for primary care providers and specialists. Am J Med, 2014; 127:e11–e4.
27.
Ministry of Health.. Pakistan. 2017. Available at http://health.punjab.gov.pk/Prevention_and_Control_of_Hepatitis (Accessed April30, 2017).
28.
Pakistan Health Research Council.. 2017. Available at http://phrc.org.pk/hepatitis.html (Accessed April30, 2017).
29.
PMDC, 2013. Available at www.pmdc.org.pk/Statistics/tabid/103/Default.aspx (Accessed April20, 2017).
30.
QureshiH. Pakistan: prevention & control of viral hepatitis. 2015. Available at www.viralhepatitisaction.org/sites/default/files/AASLD%20Humas%20presentation%203%20Nov.pdf (Accessed May1, 2017).
31.
RathoreJA, ShahMA, and MehrajA. Hepatitis C virus transmission risk factors. J Ayub Med Coll Abbottabad, 2012; 24:106–108.
32.
RazaH, AhmadT, and AfzalMS. HCV, Interferon therapy response, direct acting antiviral therapy revolution and Pakistan: future perspectives. Asian Pac J Cancer Prev, 2015; 16:5583–5584.
33.
TovoPA, CalitriC, ScolfaroC, et al.Vertically acquired hepatitis C virus infection: correlates of transmission and disease progression. World J Gastroenterol, 2016; 22:1382–1392.
34.
UmerM, and IqbalM. Hepatitis C virus prevalence and genotype distribution in Pakistan: comprehensive review of recent data. World J Gastroenterol, 2016; 22:1684–1700.
35.
WaheedY, SaeedU, SafiSZ, et al.Awareness and risk factors associated with barbers in transmission of hepatitis B and C from Pakistani population: barber's role in viral transmission. Asian Biomedicine, 2010; 4:435–442.
36.
WHO Regional Office for the Eastern Mediterranean. The growing threats of hepatitis B and hepatitis C in the Eastern Mediterranean Region: a call for action. EM/RC56/3. 2009. (Accessed April30, 2017).
37.
WHO, Pakistan.. Maternal and Perinatal Health Profile. 2013. Available at www.who.int/maternal_child_adolescent/epidemiology/profiles/maternal/pak.pdf?ua=1 (Accessed April30, 2017).
38.
World Health Organization (WHO), 2012. Available at http://pakobserver.net/detailnews.asp?id=168585 (Accessed April30, 2017).
39.
World Health Organization (WHO), 2013. Available at www.emro.who.int/pak/programmes/blood-safety.html (Accessed April30, 2017).
40.
World Health Organization (WHO), 2017. Available at www.emro.who.int/pak/programmes/prevention-a-control-of-hepatitis.html (Accessed April30, 2017).
41.
ZarkoonAK, ShahK, RehmanH, et al.Hepatitis C Virus infection in patients on long term hemodialysis. G J M S, 2008; 6:1–4.
